Ambrose Kristen
Insider CIK 1856587 · VRTX SVP & Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-08-28 | 2026-09-01 | 5,000 | — | $0 | 11,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-08-28 | 2026-09-01 | 5,000 | — | $0 | 11,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-26 | 2026-03-02 | 357 | $483.36 | $172.6K | 6,624 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-25 | 2026-02-26 | 223 | $486.35 | $108.5K | 6,981 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-24 | 2026-02-26 | 546 | $485.11 | $264.9K | 7,204 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-18 | 2026-02-19 | 638 | $473.68 | $302.2K | 7,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-17 | 2026-02-19 | 1,557 | $489.46 | $762.1K | 8,388 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-17 | 2026-02-19 | 598 | $483.75 | $289.3K | 9,945 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-02-17 | 2026-02-19 | 1,809 | — | $0 | 10,543 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-13 | 2026-02-18 | 1,393 | $487.76 | $679.4K | 8,734 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-11 | 2026-02-12 | 1,376 | $460.43 | $633.6K | 10,127 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-10 | 2026-02-12 | 592 | $468.41 | $277.3K | 11,503 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-01-22 | 2026-01-26 | 1,300 | — | $0 | 12,095 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-01-22 | 2026-01-26 | 2,950 | — | $0 | 10,795 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-26 | 2025-02-28 | 1,241 | $479.61 | $595.2K | 7,845 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-02-25 | 2025-02-26 | 884 | $480.95 | $425.2K | 9,086 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-24 | 2025-02-26 | 828 | $483.28 | $400.2K | 9,970 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-02-18 | 2025-02-19 | 671 | $455.06 | $305.3K | 10,798 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-14 | 2025-02-19 | 564 | $463.46 | $261.4K | 11,469 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-12 | 2025-02-14 | 2,080 | — | $0 | 12,033 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-02-11 | 2025-02-12 | 1,376 | $459.83 | $632.7K | 9,953 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-10 | 2025-02-12 | 591 | $467.98 | $276.6K | 11,329 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-04 | 2025-02-06 | 2,566 | — | $0 | 10,066 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-04 | 2025-02-06 | 1,854 | — | $0 | 11,920 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-04-02 | 2024-04-03 | 240 | $419.00 | $100.6K | 7,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-04-01 | 2024-04-03 | 225 | $418.10 | $94.1K | 7,740 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-02-26 | 2024-02-27 | 883 | $425.70 | $375.9K | 7,965 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-23 | 2024-02-27 | 828 | $431.79 | $357.5K | 8,848 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-02-12 | 2024-02-13 | 1,374 | $420.24 | $577.4K | 9,676 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-09 | 2024-02-13 | 591 | $422.74 | $249.8K | 11,050 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-02-07 | 2024-02-08 | 1,853 | — | $0 | 11,641 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-02-06 | 2024-02-08 | 2,950 | — | $0 | 9,788 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-05-30 | 2023-06-01 | 289 | $329.82 | $95.3K | 6,838 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2023-03-31 | 2023-04-04 | 176 | $313.74 | $55.2K | 7,127 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-02-27 | 2023-02-28 | 982 | $287.25 | $282.1K | 7,528 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-02-27 | 2023-02-28 | 183 | $288.68 | $52.8K | 7,345 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2023-02-27 | 2023-02-28 | 42 | $289.63 | $12.2K | 7,303 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2023-02-24 | 2023-02-28 | 502 | $289.12 | $145.1K | 8,510 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2023-02-01 | 2023-02-03 | 2,950 | — | $0 | 9,012 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2023-02-01 | 2023-02-03 | 2,566 | — | $0 | 6,062 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-04-25 | 2022-04-27 | 83 | $269.51 | $22.4K | 3,600 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-04-25 | 2022-04-27 | 60 | $267.37 | $16.0K | 3,763 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-04-25 | 2022-04-27 | 80 | $268.46 | $21.5K | 3,683 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2022-04-25 | 2022-04-27 | 104 | $271.68 | $28.3K | 3,496 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2022-04-01 | 2022-04-05 | 137 | $263.09 | $36.0K | 3,823 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2022-02-01 | 2022-02-03 | 2,566 | — | $0 | 3,960 | SEC↗ |